Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2002 | 1-Benzyl-3-(5′-hydroxymethyl-2′-furyl)-indazole (YC-1) derivatives as novel inhibitors against sodium nitroprusside-induced apoptosis | Lien J.-C.; Lee F.-Y.; Huang L.-J.; Pan S.-L.; JIH-HWA GUH ; Teng C.-M.; Kuo S.-C. | Journal of Medicinal Chemistry | 25 | 21 | |
2007 | The anti-inflammatory actions of LCY-2-CHO, a carbazole analogue, in vascular smooth muscle cells | Ho F.-M.; Kang H.-C.; Lee S.-T.; Chao Y.; Chen Y.-C.; Huang L.-J.; WAN-WAN LIN | Biochemical Pharmacology | 44 | 42 | |
2004 | The anti-inflammatory carbazole, LCY-2-CHO, inhibits lipopolysaccharide- induced inflammatory mediator expression through inhibition of the p38 mitogen-activated protein kinase signaling pathway in macrophages | Ho F.-M.; Lai C.-C.; Huang L.-J.; Kuo T.C.; Chao C.M.; WAN-WAN LIN | British Journal of Pharmacology | 82 | 79 | |
2015 | BC3EE2,9B, a synthetic carbazole derivative, upregulates autophagy and synergistically sensitizes human GBM8901 glioblastoma cells to temozolomide | Chen C.-M.; Syu J.-P.; Way T.-D.; Huang L.-J.; Kuo S.-C.; Lin C.-T.; Lin C.-L.; CHUNG-TIEN LIN | International Journal of Molecular Medicine | 13 | 14 | |
2005 | Cell apoptosis induced by a synthetic carbazole compound LCY-2-CHO is mediated through activation of caspase and mitochondrial pathways | Hsu M.-J.; Chao Y.; Chang Y.-H.; Ho F.-M.; Huang L.-J.; Huang Y.-L.; TIEN-YAU LUH ; Chen C.-P.; WAN-WAN LIN | Biochemical Pharmacology | 24 | 22 | |
2015 | Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: A nationwide multicenter study in Taiwan | Chang Y.-Y.; Chuang Y.-C.; Siu L.K.; Wu T.-L.; Lin J.-C.; Lu P.-L.; JANN-TAY WANG ; Wang L.-S.; Lin Y.-T.; Huang L.-J.; Fung C.-P. | Journal of Microbiology, Immunology and Infection | 48 | 42 | |
2021 | Cost-benefit of reimbursement for pharmaceutical care in Taiwan | CHIEN-CHIH WU ; Tsai S.-L.; Ku P.-J.; FE-LIN LIN WU ; Huang L.-J.; Tseng W.-Y.; Li I.-H.; Wang T.-Y.; Wang M.-S.; Kuo L.-N.; Chang Y.-L.; Su H.-C.; Lin Y.-J.; Cheng Y.-D.; Chen C.-H.; Huang Y.-C.; CHI-CHUAN WANG ; LI-JIUAN SHEN | JACCP Journal of the American College of Clinical Pharmacy | 1 | 0 | |
2002 | Effect of a potent cyclooxygenase inhibitor, 5-ethyl-4-methoxy-2-phenylquinoline (KTC-5), on human platelets | Liao C.-H.; Chang Y.-L.; JIH-HWA GUH ; Kuo S.-C.; Huang L.-J.; Teng C.-M. | Journal of Pharmacy and Pharmacology | 3 | 3 | |
2016 | Erratum: Evaluation of a health-promoting school program to enhance correct medication use in Taiwan (Journal of Food and Drug Analysis(2014) 22 (271-278)) | Chi H.-Y.; Chang F.-C.; Lin H.-J.; Huang L.-J.; JUNG-CHEN CHANG ; Yeh M.-K.; Kang J.-J. | Journal of Food and Drug Analysis | 0 | 0 | |
2014 | Evaluation of a health-promoting school program to enhance correct medication use in Taiwan | Chi H.-Y.; Chang F.-C.; Lin H.-J.; Huang L.-J.; JUNG-CHEN CHANG ; Yeh M.-K.; Kang J.-J. | Journal of Food and Drug Analysis | 9 | 5 | |
1992 | HA-29: An inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets | Lin C.-H.; Kuo S.-C.; Huang L.-J.; TUR-FU HUANG ; Teng C.-M. | Thrombosis Research | 3 | 4 | |
2002 | Inhibition of Ras-mediated cell proliferation by benzyloxybenzaldehyde | Pan S.-L.; JIH-HWA GUH ; Huang Y.-W.; Chang Y.-L.; Chang C.-Y.; Huang L.-J.; Kuo S.-C.; Teng C.-M. | Journal of biomedical science | 11 | 9 | |
2020 | Recommendations and guidelines for the treatment of Clostridioides difficile infection in Taiwan | Wu K.-S.; Syue L.-S.; ARISTINE CHENG ; TING-YU YEN ; Chen H.-M.; Chiu Y.-H.; Hsu Y.-L.; Chiu C.-H.; Su T.-Y.; Tsai W.-L.; Chen W.-Y.; Huang C.-H.; Hung H.-M.; Huang L.-J.; Kuo H.-J.; Lin P.-C.; Yang C.-H.; Hong P.-L.; Lee S.S.-J.; Chen Y.-S.; Liu Y.-C.; LI-MIN HUANG ; Infectious Diseases Society of Taiwan, Medical Foundation in Memory of Dr. Deh-Lin Cheng, Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research; Education, CY Lee's Research Foundation for Pediatric Infectious Diseases; Vaccines, The 5th Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group | Journal of Microbiology, Immunology and Infection | 14 | 13 | |
2008 | Synthesis of 2,3-disubstituted 1,4-naphthoquinones as antiplatelet agents | Lien J.-C.; Wu C.-R.; Hour M.-J.; Huang L.-J.; TUR-FU HUANG ; Kuo S.-C. | Archiv der Pharmazie | 3 | 3 | |